Abbott’s Hepatitis C Drugs Clear Virus in 99% of Patients

An experimental drug combination from Abbott Laboratories wiped out all traces of the virus that causes hepatitis C in 99 percent of patients with the liver disease, a study showed.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.